Sara M. Tinsley-Vance

Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes

J. Lancet, E. Padron, O. Chan, 2023, Leukemia.

Role of Luspatercept in the Management of Lower-Risk Myelodysplastic Syndromes

Mark Davis, Sara M Tinsley-Vance, O. Ajayi, 2023, Journal of the advanced practitioner in oncology.

Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes

J. Lancet, E. Padron, K. Sweet, 2021, Blood.

Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.

J. Lancet, E. Padron, K. Sweet, 2024, Clinical lymphoma, myeloma & leukemia.